Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

2
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
2
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

2
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
2
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
Heart Failure V: Nursing Interventions01:30

Heart Failure V: Nursing Interventions

2
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
2
Cancer Therapies02:49

Cancer Therapies

7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of body mass index with complications in cardiac implantation electronic devices: A retrospective single-center cohort study.

Medicine·2026
Same author

Feasibility and safety of coronary catheter rolling technique (Jahanzeb technique) for radial artery catheterization on arterial perforation and radial artery patency.

The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology·2026
Same author

Clinical and Angiographic Predictors of No-Reflow and Its Impact on Outcomes in ST-Elevation Myocardial Infarction: A Retrospective Study.

Clinical cardiology·2026
Same author

Skin Closure Techniques After Cardiac Implantable Electronic Device Implantation and Their Impact on Pocket Complications: A Systematic Review and Meta-Analysis.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·2026
Same author

Role of Personalized Medicine in Myocardial Infarction With Nonobstructive Coronary Artery Disease (MINOCA): An Updated Review.

Cardiology in review·2026
Same author

Apolipoprotein A-I (CSL112) and Cardiovascular Outcomes in Atherosclerotic Cardiovascular Disease: A Scoping Review.

Clinical cardiology·2026

Related Experiment Video

Updated: Jun 10, 2025

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.6K

Cardiovascular Interventions in Patients With Active and Advanced Malignancy: An Updated Review.

Fahad Waqar1, Ayesha Sultan1, Romeet R Bathija1

  • 1Department of Cardiovascular Analytics Group, Islamabad, Pakistan.

Journal of Community Hospital Internal Medicine Perspectives
|October 11, 2024
PubMed
Summary
This summary is machine-generated.

This review examines invasive cardiac interventions for patients with advanced cancer, considering unique risks and survival expectations. It aims to guide clinicians in making informed treatment decisions for complex cancer and cardiovascular disease cases.

Keywords:
Active advanced malignanciesCardiovascular diseaseInvasive cardiac interventionsShared decision-makingSurvival expectations

More Related Videos

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

2.2K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

394

Related Experiment Videos

Last Updated: Jun 10, 2025

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.6K
Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

2.2K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

394

Area of Science:

  • Cardiology and Oncology
  • Interventional Cardiology
  • Cancer Survivorship

Background:

  • Evidence for invasive cardiac interventions often excludes patients with advanced malignancies.
  • The intersection of cancer and cardiovascular disease presents unique treatment challenges.
  • Limited data exists on the efficacy and safety of cardiac procedures in active, advanced cancer patients.

Purpose of the Study:

  • To comprehensively review invasive cardiac interventions in patients with active, advanced cancer.
  • To analyze the applicability of procedures across various cardiovascular conditions in this population.
  • To provide a framework for clinical decision-making regarding cardiac interventions in cancer patients.

Main Methods:

  • Systematic literature review of invasive cardiac interventions in advanced cancer patients.
  • Analysis of cardiovascular conditions including myocardial infarction, coronary artery disease, aortic stenosis, and cardiomyopathy.
  • Evaluation of contemporary survival expectations for various advanced malignancies.

Main Results:

  • Invasive cardiac interventions are primarily based on evidence from trials not including advanced cancer patients.
  • Benefits and risks of cardiac procedures in advanced malignancy require careful consideration.
  • Competing mortality from cancer influences treatment recommendations.

Conclusions:

  • A nuanced approach is needed for invasive cardiac interventions in active, advanced cancer.
  • Understanding cancer prognosis is crucial for assessing cardiac intervention appropriateness.
  • This review offers guidance for clinicians managing complex cancer and cardiovascular disease.